Unlock instant, AI-driven research and patent intelligence for your innovation.

Molecular marker for hepatopathy aggravation and application thereof

A biomarker and severe disease technology, applied in the field of liver disease diagnosis, to achieve the effect of optimization and simplicity

Pending Publication Date: 2021-04-09
THE AFFILIATED HOSPITAL OF HANGZHOU NORMAL UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Sequence-specific hybridization probes for more than 2-plex reactions are rarely reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Molecular marker for hepatopathy aggravation and application thereof
  • Molecular marker for hepatopathy aggravation and application thereof
  • Molecular marker for hepatopathy aggravation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Screening of Liver Fibrosis Biomarkers

[0034] In the GEO and ArrayExpress databases, "NAFLD liver fibrosis" was used as the keyword to search for fatty liver-associated liver fibrosis gene chip data. Data requirements:

[0035] 1) The selected data set must be the expression profile data of the whole genome;

[0036] 2) The selected data set contains fibrosis and control expression profiles; all samples are from human liver tissue.

[0037] 3) The selected data set must include more than 4 samples.

[0038] The GSE49541 dataset was first chosen as an exploratory cohort because it contained the largest number of NAFLD samples with clear fibrosis stages. The data of the validation cohort came from E-MEXP-3291, GSE48452 and GSE59045; the other 5 datasets were fatty liver samples, but without clinical information annotations such as fibrosis (GSE17470, GSE24807, GSE37031, GSE46300 and GSE63067). The positive control uses the HBV-related liver fibrosis GSE840...

Embodiment 2

[0043] The dye method PCR quantitative detection of embodiment 2, EFEMP1, THBS2, LUM

[0044] Research objects: 20 patients with fatty liver disease, and the diagnosis of fatty liver was in accordance with the "Guidelines for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in China (2010 Revised Edition)". Tissue samples after liver puncture were collected in the Affiliated Hospital of Hangzhou Normal University. Liver biopsies were routinely stained with HE, and professional pathologists scored for fibrosis staging. Among them, there were 12 cases of fibrosis stage 0-1, and 8 cases of stage 2-4.

[0045] experimental method:

[0046] 1. RNA extraction

[0047] 1) About 50 mg of liver tissue was placed in a 1.5 ml EP tube with small steel balls, 1 ml of Trizol solution was added, put into a grinder, and grind rapidly. In the centrifuge, centrifuge at 12000r / min, 4°C for 5min, after centrifugation, let stand at room temperature for 5min.

[0048] 2) Separat...

Embodiment 3

[0072] Embodiment 3, universal probe expression detection

[0073] 1. Standard product construction

[0074] According to the sequence of the coding region of the human THBS2 gene (Genbank gene accession number is NM_003247), the full-length cDNA vector containing THBS2 was constructed in the pGEM-T vector and synthesized by Qingke Bio. The plasmid standard was named pGEM-THBS2.

[0075] According to the coding region sequence of human LUM gene (Genbank gene accession number is NM_002345), the full-length cDNA vector containing LUM was constructed in pGEM-T vector and synthesized by Qingke Bio. The plasmid standard was named pGEM-LUM.

[0076] According to the sequence of the coding region of human EFEMP1 gene (Genbank gene accession number is NM_001039349), the full-length cDNA vector containing EFEMP1 was constructed in pGEM-T vector and synthesized by Qingke Bio. The plasmid standard was named pGEM-EFEMP1.

[0077] The plasmid DNA was digested with ApaI to linearize the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a biomarker for hepatopathy aggravation and application thereof. The molecular marker for the hepatopathy aggravation comprises at least one of three genes including EFEMP1, THBS2 and LUM. The biomarker has significant correlation with hepatic fibrosis progression, and can be used for preparing hepatic fibrosis auxiliary diagnosis or prognosis preparations. The biomarker preparation includes a quantitative polymerase chain reaction (PCR) primer, a reagent and a use method of the reagent, can screen and judge the hepatic fibrosis degree of the hepatopathy, and provides an effective basis for clinical individualized intervention treatment.

Description

technical field [0001] The invention relates to the technical field of liver disease diagnosis, and relates to a biomarker for the progression of liver fibrosis and its application. Specifically, the present invention relates to EFEMP1, THBS2, LUM genes and the application of the genes in auxiliary diagnosis or prognosis of liver disease fibrosis. Background technique [0002] Various etiologies of the current liver disease spectrum include viral hepatitis, alcoholic liver disease, metabolic liver disease, drug-induced liver disease, genetic liver disease, etc., and liver fibrosis is a key node in the progression to severe disease in the natural history of many liver diseases. If liver fibrosis continues to develop to the middle and late stages, liver cirrhosis will appear, and the morphology will show diffuse fibrosis, structural damage of liver lobules with abnormal nodule formation, and clinical manifestations such as portal hypertension and liver failure. During the cou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883C12Q1/6851G01N33/68C12N15/11
CPCC12Q1/6883C12Q1/6851G01N33/6893C12Q2600/158C12Q2600/118C12Q2600/16G01N2800/085G01N2800/52C12Q2531/113C12Q2545/101C12Q2563/107C12Q2537/143
Inventor 杨劲施军平
Owner THE AFFILIATED HOSPITAL OF HANGZHOU NORMAL UNIV